Oddrun Anita Gudbrandsen
Bergen, 5053, Norway
NCT Number: NCT03538821
A high intake of fish is associated with positive health effects, including prevention and treatment of chronic non-communicable diseases, such as cardiovascular diseases (CVDs) and type 2 diabetes. These health effects have traditionally been attributed to the omega-3 fatty acids in fatty fish, but recent studies have suggested that also fish proteins may improve biomarkers of metabolic disease. Intake of cod fillet have previously shown beneficial effects on blood lipids, glucose regulation and body composition in adults with overweight or obesity. Health effect of cod residual material from fillet production (i.e., head, backbone, skin, cutoffs and entrails) have so far not been investigated, but residuals from other fish species have shown promising effects on glucose regulation in rats. The main aim of the current study is to investigate the effects of protein from cod fillet and cod residuals on serum lipids, glucose regulation and inflammatory markers in healthy overweight or obese adults.
Looking for future studies?
Notify Me20 year–55 year
All sexes
Interventional
Not applicable
Bergen, 5053, Norway
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intact cod protein from fillet 8 g protein daily for 8 weeks
Intact cod protein from residual material, 8 g protein daily for 8 weeks
Control group receive tablet containing fillers
Time frame: 8 weeks
Lipids will be measured in fasting serum samples
Time frame: 8 weeks
Glucose, insulin and GLP-1 and will be measured in serum/plasma sampled in fasting and postprandial conditions.
Time frame: 8 weeks
Cytokines will be measured in fasting serum/plasma
Time frame: 8 weeks
Percent body fat will be measured using bioimpedance
University of Bergen
Other
The Effects of a Daily Intake of Protein From Cod Fillet and Cod Residual Material for 8 Weeks on Serum Lipids and Fatty Acids, Glucose Regulation and Inflammation Markers in Overweight or Obese Adults: A Randomized Controlled Trial.
Acronym: COD2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06490263
Body Weight, Healthy
Beijing, Beijing Municipality, China
View Trial DetailsNCT06500429
Body Weight, Healthy
Tempe, Arizona, United States
View Trial DetailsNCT06494449
Body Weight, Healthy
Addison, Illinois, United States
View Trial DetailsNCT04810572
Body Weight, Digestive System Diseases
São Paulo, Brazil
View Trial Details